FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898973729> ?p ?o ?g. }

• W2898973729 endingPage "605" @default.
• W2898973729 startingPage "598" @default.
• W2898973729 abstract "Introduction: Super-refractory status epilepticus is defined as status epilepticus that persists or recurs 24 hours after anaesthetic therapy onset or after its withdrawal. It is mostly found in intensive care units and carries high mortality but good long-term prognosis for those who survive. In contrast with the initial phases of status epilepticus, treatment lacks strong scientific evidence and is mostly derived from case reports or small case series.Objective: To propose a protocol for the treatment of super-refractory status epilepticus in level III intensive care units, focusing on the treatment strategies to control clinical and/or electroencephalographic epileptic activity.Material and Methods: Narrative review of the literature by PubMed search. Available evidence was discussed in consensus meetings by intensive care and neurology experts’ from a level III intensive care unit and one of the Portuguese reference centres for the treatment of refractory epilepsy, respectively.Results: Anaesthetics with the highest level of evidence are propofol, midazolam, thiopental and ketamine. These represent the basis of the treatment of super-refractory status epilepticus and should be used in combination with antiepileptic drugs. The level of evidence for the latter is lower, however, levetiracetam, topiramate, pregabalin, lacosamide, valproic acid, phenytoin and perampanel may be recommended. Alternative therapeutic strategies with very low level of evidence are recommended in cases of total absence of clinical response, such as magnesium sulphate, pyridoxine, ketogenic diet, therapeutic hypothermia and immunosupression.Conclusion: We propose a treatment protocol based on a sequential combination of anaesthetics, anti-epileptic drugs and alternative therapies. Strategies to evaluate treatment response and to wean drugs based on clinical results are also proposed." @default.
• W2898973729 created "2018-11-09" @default.
• W2898973729 creator A5016531940 @default.
• W2898973729 creator A5063209647 @default.
• W2898973729 creator A5066740308 @default.
• W2898973729 creator A5068220828 @default.
• W2898973729 creator A5074124225 @default.
• W2898973729 creator A5085147687 @default.
• W2898973729 creator A5009352745 @default.
• W2898973729 date "2018-10-31" @default.
• W2898973729 modified "2023-10-18" @default.
• W2898973729 title "Consensus Protocol for the Treatment of Super-Refractory Status Epilepticus" @default.
• W2898973729 cites W1488352046 @default.
• W2898973729 cites W1606313652 @default.
• W2898973729 cites W1803953876 @default.
• W2898973729 cites W1856414226 @default.
• W2898973729 cites W2050104133 @default.
• W2898973729 cites W2056821940 @default.
• W2898973729 cites W2084468981 @default.
• W2898973729 cites W2104047366 @default.
• W2898973729 cites W2129658473 @default.
• W2898973729 cites W2145861835 @default.
• W2898973729 cites W2513012364 @default.
• W2898973729 doi "https://doi.org/10.20344/amp.9679" @default.
• W2898973729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30387431" @default.
• W2898973729 hasPublicationYear "2018" @default.
• W2898973729 type Work @default.
• W2898973729 sameAs 2898973729 @default.
• W2898973729 citedByCount "11" @default.
• W2898973729 countsByYear W28989737292019 @default.
• W2898973729 countsByYear W28989737292020 @default.
• W2898973729 countsByYear W28989737292021 @default.
• W2898973729 countsByYear W28989737292022 @default.
• W2898973729 crossrefType "journal-article" @default.
• W2898973729 hasAuthorship W2898973729A5009352745 @default.
• W2898973729 hasAuthorship W2898973729A5016531940 @default.
• W2898973729 hasAuthorship W2898973729A5063209647 @default.
• W2898973729 hasAuthorship W2898973729A5066740308 @default.
• W2898973729 hasAuthorship W2898973729A5068220828 @default.
• W2898973729 hasAuthorship W2898973729A5074124225 @default.
• W2898973729 hasAuthorship W2898973729A5085147687 @default.
• W2898973729 hasBestOaLocation W28989737291 @default.
• W2898973729 hasConcept C118552586 @default.
• W2898973729 hasConcept C121332964 @default.
• W2898973729 hasConcept C142424586 @default.
• W2898973729 hasConcept C16568411 @default.
• W2898973729 hasConcept C177713679 @default.
• W2898973729 hasConcept C2776376669 @default.
• W2898973729 hasConcept C2777332695 @default.
• W2898973729 hasConcept C2777341932 @default.
• W2898973729 hasConcept C2777683783 @default.
• W2898973729 hasConcept C2778139780 @default.
• W2898973729 hasConcept C2778186239 @default.
• W2898973729 hasConcept C2778337148 @default.
• W2898973729 hasConcept C2779253243 @default.
• W2898973729 hasConcept C2781176495 @default.
• W2898973729 hasConcept C2987404301 @default.
• W2898973729 hasConcept C42219234 @default.
• W2898973729 hasConcept C71924100 @default.
• W2898973729 hasConcept C87355193 @default.
• W2898973729 hasConceptScore W2898973729C118552586 @default.
• W2898973729 hasConceptScore W2898973729C121332964 @default.
• W2898973729 hasConceptScore W2898973729C142424586 @default.
• W2898973729 hasConceptScore W2898973729C16568411 @default.
• W2898973729 hasConceptScore W2898973729C177713679 @default.
• W2898973729 hasConceptScore W2898973729C2776376669 @default.
• W2898973729 hasConceptScore W2898973729C2777332695 @default.
• W2898973729 hasConceptScore W2898973729C2777341932 @default.
• W2898973729 hasConceptScore W2898973729C2777683783 @default.
• W2898973729 hasConceptScore W2898973729C2778139780 @default.
• W2898973729 hasConceptScore W2898973729C2778186239 @default.
• W2898973729 hasConceptScore W2898973729C2778337148 @default.
• W2898973729 hasConceptScore W2898973729C2779253243 @default.
• W2898973729 hasConceptScore W2898973729C2781176495 @default.
• W2898973729 hasConceptScore W2898973729C2987404301 @default.
• W2898973729 hasConceptScore W2898973729C42219234 @default.
• W2898973729 hasConceptScore W2898973729C71924100 @default.
• W2898973729 hasConceptScore W2898973729C87355193 @default.
• W2898973729 hasIssue "10" @default.
• W2898973729 hasLocation W28989737291 @default.
• W2898973729 hasLocation W28989737292 @default.
• W2898973729 hasLocation W28989737293 @default.
• W2898973729 hasLocation W28989737294 @default.
• W2898973729 hasOpenAccess W2898973729 @default.
• W2898973729 hasPrimaryLocation W28989737291 @default.
• W2898973729 hasRelatedWork W2084445552 @default.
• W2898973729 hasRelatedWork W2137273926 @default.
• W2898973729 hasRelatedWork W2167848211 @default.
• W2898973729 hasRelatedWork W2508027197 @default.
• W2898973729 hasRelatedWork W2600614460 @default.
• W2898973729 hasRelatedWork W2898973729 @default.
• W2898973729 hasRelatedWork W3134387711 @default.
• W2898973729 hasRelatedWork W3159524118 @default.
• W2898973729 hasRelatedWork W4256651757 @default.
• W2898973729 hasRelatedWork W174147428 @default.
• W2898973729 hasVolume "31" @default.
• W2898973729 isParatext "false" @default.
• W2898973729 isRetracted "false" @default.

• next